BIOMAT Database Logo BIOMAT Database Logo

Letter: Immunotherapy with intravenous B.C.G. 1973

J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Letter: Immunotherapy with intravenous B.C.G.
July 1974, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Active immunotherapy with B.C.G. for melanoma.
January 1975, Panminerva medica,
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Immunoprophylaxis and immunotherapy of leukaemia with B.C.G.
October 1972, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Letter: B.C.G. at school.
November 1975, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Effect of intravenous B.C.G. in guineapigs and pertinence to cancer immunotherapy in man.
June 1975, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Active immunotherapy with B.C.G. for recurrent malignant melanoma.
June 1973, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Regional immunotherapy of lung cancer with intrapleural B.C.G.
February 1976, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Letter: Methods of B.C.G. vaccination.
August 1974, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Letter: B.C.G. in rheumatoid arthritis.
September 1974, Lancet (London, England),
J A Whittaker, and J S Lilleyman, and A Jacobs, and I Balfour
Letter: B.C.G. and immunological anergy.
May 1974, Lancet (London, England),
Copied contents to your clipboard!